Research Article
[Retracted] Effects of Albumin Supplements on In-Hospital Mortality in Patients with Sepsis or Septic Shock: A Systemic Review and Meta-Analysis
Table 2
Subgroup analysis for the effects of albumin vs. crystalloid on 28-day mortality of sepsis and/or septic shock.
| Subgroup analysis | Studies | Pooled results | Heterogeneity | Effect size (95% CI) | value | I 2 | value |
| Albumin concentration | | OR | | | | 4%-5% | 4 | 1.01 (0.86–1.20) | 0.861 | 54.0% | 0.089 | 20%–25% | 5 | 1.002 (0.88–1.18) | 0.798 | 0% | 0.461 | Sample size | | OR | | | | >650 | 5 | 0.99 (0.88–1.11) | 0.834 | 35.3% | 0.186 | ≤650 | 4 | 1.23 (0.92–1.66) | 0.164 | 0% | 0.555 | Study type | | OR | | | | RCT | 6 | 0.96 (0.85–1.10) | 0.576 | 27.7% | 0.227 | Retrospective study | 3 | 1.17 (0.95–1.43) | 0.139 | 0% | 0.668 |
|
|